Quick Answer
CANNAPHARMARX, INC. reported Operating Income of -$3.35 million for fiscal year 2025.
CANNAPHARMARX, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$3.35M | +7.8% |
| 2024 | -$3.63M | -129.6% |
| 2023 | -$1.58M | +69.7% |
| 2022 | -$5.21M | -74.1% |
| 2021 | -$2.99M | +79.3% |
| 2020 | -$14.49M | +9.3% |
| 2019 | -$15.98M | -1574.3% |
| 2018 | -$954.3K | -14287.4% |
| 2017 | -$6.6K | +99.3% |
| 2016 | -$1.00M | +91.4% |
| 2015 | -$11.65M | -193.2% |
| 2014 | -$3.97M | -4848.9% |
| 2013 | -$80.3K | +10.3% |
| 2012 | -$89.6K | +7.8% |
| 2011 | -$97.1K | -116.6% |
| 2010 | $585.6K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$935.6K | -81.3% | -11.3% |
| June 30, 2025 | -$841.0K | -62.4% | -26.0% |
| March 31, 2025 | -$667.7K | +15.5% | -29.4% |
| September 30, 2024 | -$516.0K | +22.7% | +0.4% |
| June 30, 2024 | -$517.8K | +42.0% | +34.5% |
| March 31, 2024 | -$790.2K | -9.7% | -18.4% |
| September 30, 2023 | -$667.5K | -13.4% | +25.2% |
| June 30, 2023 | -$892.9K | -26.8% | -24.0% |
- CANNAPHARMARX, INC. showed an increase of +7.8% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, CANNAPHARMARX, INC.’s operating income has declined by 671.7% (from $585.6 thousand to -$3.35 million).
- The most recent figure is from CANNAPHARMARX, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: